{"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"groups":[{"description":"Fludarabine 30 mg/m\\^2 intravenous (IV) for 4 Days + Melphalan 140 mg/m\\^2 IV for 1 Day + Rituximab 375 mg/m\\^2 IV once weekly + Cord Blood Transplantation + Stem Cell Transplantation Infusion","id":"BG000","title":"Cellular Therapy With Cord Blood Cells"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"17","value":"44"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"19"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}